Weight loss skincare is on the way: New anti-aging treatment was designed to battle Ozempic face

You wanted a tighter waistline — and ended up with a looser face.As Ozempic and other GLP-1 weight-loss medications skyrocket in popularity, one unflattering side effect is earning quite a bit of attention: “Ozempic face,” the gaunt, prematurely aged look some patients develop after shedding pounds at record speed.Now, the skincare industry is rushing to keep up — and a new treatment has emerged specifically designed to counteract the deflated cheeks, deep wrinkles and sagging skin that follow fast weight loss.The reason some people on these drugs can sometimes look much older after weight loss isn’t actually because of the drug itself — it’s the speedy slim down that does it.“Patients on GLP-1 medications such as Ozempic often experience rapid weight loss, which leads to noticeable changes in facial skin such as deflation, deep wrinkles, dehydration and density loss,” plastic surgeon Dr.Marc Ronert told the Post.“When fat and muscle volume drop quickly, the skin can’t always bounce back, leading to a prematurely aged appearance.“These skin changes are not unique to Ozempic.

Anyone who’s lost weight quickly can experience facial deflation, which causes skin agin.”But as millions of Americans turn to these medications, an entire market is emerging to support the skin, hair and hormonal side effects of fast-track weight loss.A new daily supplement designed to combat “Ozempic face” hit shelves late last year, while analysts predict we’re only seeing the beginning of this trend.“Brands can better serve these consumers by focusing on solutions that enhance skin elasticity and firmness,” Lindsay Cameron, a health and wellness analyst at Mintel, told Glossy.“There’s a promising opportunity for beauty and personal care brands to tackle issues like loose skin, premature aging and hair loss, which frequently accompany rapid weight loss, despite users’ nutritional and supplemental efforts.”That’s why Ronert recently launched VOL...